Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
535K
-
Shares change
-
+535K
-
Total reported value, excl. options
-
$1.18M
-
Value change
-
+$1.18M
-
Number of buys
-
9
-
Price
-
$2.19
Significant Holders of ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) as of Q2 2018
9 filings reported holding ATOS - ATOSSA THERAPEUTICS, INC. - Common Stock as of Q2 2018.
ATOSSA THERAPEUTICS, INC. - Common Stock (ATOS) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 535K shares
of 129M outstanding shares and own 0.41% of the company stock.
Largest 9 shareholders include SABBY MANAGEMENT, LLC (341K shares), Anson Funds Management LP (109K shares), VANGUARD GROUP INC (33.9K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (24.2K shares), GEODE CAPITAL MANAGEMENT, LLC (15.8K shares), UBS Group AG (9.13K shares), DEUTSCHE BANK AG\ (1.1K shares), BlackRock Inc. (617 shares), and Advisor Group, Inc. (416 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.